EBIT: Income before interest and taxes.
Appili Therapeutics Inc. (APLIF) had EBIT of $-0.51M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.08M |
|
$-0.68M |
|
-- |
|
$0.08M |
|
$0.60M |
|
$-0.51M |
|
$-0.16M |
|
$-0.67M |
|
$-0.67M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
|
EBIT |
$-0.51M |
$-0.51M |
|
128.37M |
|
128.37M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.38M |
|
$0.01M |
|
$0.01M |
|
$0.39M |
|
$11.62M |
|
$0.53M |
|
$0.53M |
|
$12.15M |
|
$-11.75M |
|
$-11.75M |
|
$-11.75M |
|
128.37M |
|
| Cash Flow Statement Financials | |
$-0.75M |
|
-- |
|
$0.02M |
|
$0.88M |
|
$0.15M |
|
$-0.73M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-0.05 |
|
-0.76 |
|
100.00% |
|
-623.85% |
|
-623.85% |
|
-- |
|
-817.25% |
|
-825.79% |
|
$-0.75M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
-- |
|
0.64 |
|
140.23 |
|
5.79% |
|
5.79% |
|
-173.29% |
|
6.07% |
|
$-0.09 |
|
$-0.01 |
|
$-0.01 |
|